Study of ESG401 in Adults With Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast|Neoplasms, Lung|Neoplasms,Colorectal|Neoplasms, Bladder|Neoplasm of Stomach|Neoplasms,Ovarian
Interventions: DRUG: ESG401
Sponsor: Shanghai Escugen Biotechnology Co., Ltd